U.S. Healthtech Stock News

Klaviyo (NYSE:KVYO) has authorized a $500 million share repurchase program. The company also announced a new partnership with Google focused on AI driven customer experiences. The collaboration aims to connect search, messaging, and advertising into a more unified marketing platform for brands. Klaviyo is making these moves with its stock trading at $18.21 and a value score of 5, alongside mixed recent performance, up 14.7% over the past week but down 18.0% over the past month. Returns are...

Madison Square Garden Sports (MSGS) has drawn fresh attention after its board unanimously approved exploring a spin off that would separate the New York Knicks and New York Rangers into two independent, publicly traded companies. See our latest analysis for Madison Square Garden Sports. That spin off announcement and the CFO transition come after a strong run in the share price, with Madison Square Garden Sports posting a 90 day share price return of 48.11% and a 1 year total shareholder...

Marex Group (MRX) has drawn fresh attention after recent share price moves, with the stock showing double digit returns over the month and past 3 months. This has prompted investors to reassess the diversified financial services platform. See our latest analysis for Marex Group. The recent rally sits on top of a broader upswing, with a 30 day share price return of 10.97% and year to date share price return of 15.47%. The 1 year total shareholder return of 23.13% points to building momentum as...

OpenText recently expanded its FY26 share repurchase program by US$200 million to US$500 million and approved buying back up to 24,906,456 shares for cancellation, while also selling its Vertica analytics database business to Rocket Software for US$150 million. Together, the larger buyback and Vertica divestiture highlight a shift toward returning more capital to shareholders while sharpening the company’s focus on core information management offerings. We’ll now examine how the expanded...

NeoGenomics (NEO) has drawn fresh attention after launching RaDaR ST, a circulating tumor DNA assay designed to detect molecular residual disease in blood using patient specific panels and advanced bioinformatics. See our latest analysis for NeoGenomics. Despite the RaDaR ST launch and recent earnings and guidance updates, NeoGenomics' 30 day share price return of 21.23% and year to date share price return of 19.22% both point to fading near term momentum. At the same time, the 5 year total...

RadNet (RDNT) closed out FY 2025 with Q4 revenue of US$547.7 million and basic EPS of roughly US$0.01 loss, while trailing twelve month figures show revenue at about US$2.0 billion and basic EPS of roughly US$0.25 loss. The company has seen quarterly revenue move from US$471.4 million in Q1 2025 to US$547.7 million in Q4 2025, with basic EPS swinging between a US$0.51 loss and US$0.19 profit over the same span. This sets up a story that focuses on how quickly margins can stabilize from...

Linde (LIN) is back in focus as the stock reacts to rising natural gas costs tied to Middle East tensions and the closure of the Strait of Hormuz, a key route for global energy supplies. See our latest analysis for Linde. Beyond the immediate reaction to energy cost concerns, Linde’s share price has shown strong momentum, with an 11.46% 30 day share price return and an 18.70% year to date share price return. Over a longer horizon, the 1 year total shareholder return of 11.67% and 5 year total...

EOG Resources (EOG) has drawn fresh attention after its recent share move, with the stock last closing at $128.65. That puts its recent performance and underlying fundamentals back in focus for investors. See our latest analysis for EOG Resources. The recent 1 day share price return of 3.68% extends a stronger run, with a 30 day share price return of 14.73% and a 5 year total shareholder return of 120.24%. This suggests momentum has been building over both shorter and longer periods. If this...

Celsius Holdings (CELH) just reported fourth quarter and full year 2025 results, showing strong revenue growth and a swing to quarterly profitability. The report was followed by a sharp share price pullback as investors locked in gains. See our latest analysis for Celsius Holdings. That profit taking drop of 8.13% on the 1 day share price return comes after a strong run, with a 90 day share price return of 20.62% and a 1 year total shareholder return of 92.01%. Momentum has cooled slightly,...

Why BNY’s new preferred stock moves matter for common shareholders Bank of New York Mellon Corporation (BK) has launched a proposed public offering of Series M Noncumulative Perpetual Preferred Stock via depositary shares, alongside a completed US$500m variable rate preferred fixed income deal. For you as a common shareholder, these preferred moves sit alongside BNY’s push into blockchain settlement, tokenization and AI driven onboarding. Together, they raise questions about capital...

In late February 2026, Trupanion reported its full-year 2025 results, highlighting a return to profitability with net income of US$19.4 million and surpassing US$1.00 billion in annual subscription revenue driven by pricing aligned to rising veterinary costs and improved operating margins. The company also issued an optimistic 2026 outlook, projecting total revenue of about US$1.55–US$1.58 billion and targeting adjusted operating income growth of roughly 19%, while exploring lower-priced...

In recent days, escalating conflict involving Iran and effective disruption around the Strait of Hormuz have pushed global oil prices sharply higher, focusing attention on Exxon Mobil’s large upstream operations. At the same time, Exxon Mobil confirmed that director Jeffrey W. Ubben will not seek re-election at the May 2026 shareholder meeting, though his departure is described as unrelated to the company. These developments highlight how sudden geopolitical supply risks can reinforce the...

Spire (SR) has drawn fresh attention after terminating the certificate of designations for its 5.90% Series A Cumulative Redeemable Perpetual Preferred Stock, along with recent earnings and dividend updates in the natural gas utilities sector. See our latest analysis for Spire. That change to Spire’s capital structure comes as the share price trades at US$91.66, with a 30 day share price return of 8.49% and a 1 year total shareholder return of 22.45%. The 5 year total shareholder return of...

In late February 2026, Pfizer and Astellas reported that PADCEV plus Keytruda cut the risk of tumor recurrence, progression or death in cisplatin-eligible muscle-invasive bladder cancer patients versus standard chemotherapy, while Pfizer also secured full FDA approval for BRAFTOVI-based combination therapy in first-line BRAF V600E-mutant metastatic colorectal cancer. Together, these oncology advances strengthen Pfizer’s presence in high-need cancer settings and may help offset pressure from...

Range Resources (RRC) is back in focus after reporting 2025 results with record operational efficiencies, setting a new 2026 capital plan and production guidance, and lifting its quarterly dividend payout to shareholders. See our latest analysis for Range Resources. The recent earnings beat, operational records and dividend increase appear to be feeding into solid momentum, with a 7 day share price return of 8.6% and a year to date share price return of 18.6%, while the 5 year total...

Bio-Rad Laboratories (BIO) has been drawing attention after a mixed stretch for the share price, with gains over the past year but declines over the past 3 months and year to date. See our latest analysis for Bio-Rad Laboratories. Recent trading has been choppy, with a 4.23% 7 day share price return following a weaker 30 day share price return of a 4.80% decline. A 12.23% decline over 90 days points to fading momentum despite a 9.02% 1 year total shareholder return. If this mixed performance...

Event context and recent share performance Maximus (MMS) has come onto investors’ radar after a period of mixed share performance. The stock is down roughly 22% over the past month and about 15% over the past 3 months. See our latest analysis for Maximus. Against this recent slide, Maximus still has a 1 year total shareholder return of 16.64%. However, the 3 year and 5 year total shareholder returns of 6.02% and 6.59% declines suggest fading longer term momentum. If Maximus’ move has you...

Conagra Brands (NYSE:CAG) has added John Mulligan and Pietro Satriano to its board of directors. Mulligan and Satriano bring leadership experience from Target, McDonald's, US Foods, and Loblaw. The appointments signal a focus on retail operations, finance, and foodservice expertise at the board level. Conagra Brands, trading at $19.18, sits in a challenging spot after a 20.8% decline over the past year and a 33.5% decline over five years, even with a 10.9% gain year to date. For investors...

Why the SoFiUSD partnership matters for Mastercard stock Mastercard (MA) is putting stablecoins directly into its core plumbing, partnering with SoFi to let SoFiUSD settle card transactions across its global network and plug into its Multi Token Network. For you as a shareholder or prospective investor, this move brings stablecoin adoption, blockchain based settlement and card network economics into the same conversation. It raises fresh questions about how Mastercard’s business model could...

In February 2026, Centerspace reported fourth-quarter 2025 results showing sales of US$66.62 million and a net loss of US$18.38 million, alongside full-year sales of US$273.66 million and net income of US$17.59 million. The company paired this with 2026 guidance calling for a diluted net loss per share of US$0.49 to US$0.19, signaling a potential step back after returning to profitability in 2025. Next, we’ll examine how Centerspace’s return to profit in 2025 but projected loss in 2026...

In recent weeks, Iron Mountain Inc. has seen its short interest fall by 14.69%, with 3.6% of its freely traded shares now sold short, below the peer average of 5.54%. This pullback in bearish positioning suggests a meaningful shift in sentiment, as investors appear relatively more confident in Iron Mountain’s outlook than in many of its peers. With this backdrop of easing short interest, we’ll explore how changing investor sentiment could influence Iron Mountain’s evolving investment...

AXT, Inc. has reported its fourth-quarter 2025 results, with sales of US$23.04 million and a net loss of US$3.55 million, while full-year 2025 sales reached US$88.33 million alongside a net loss of US$21.26 million. The company’s quarterly loss narrowed compared with a year earlier even as full-year losses increased, setting an interesting backdrop for its push into indium phosphide substrates for AI-related infrastructure. We’ll now examine how AXT’s efforts to expand indium phosphide...

Recent downgrades and cautious commentary on Adobe (ADBE), focused on AI driven competitive threats to its seat based software model, have pushed the stock into the spotlight for investors who are reassessing its long term positioning. See our latest analysis for Adobe. Adobe's share price has come under pressure in 2026, with a year to date share price return of 21.73% decline and a 1 year total shareholder return of 41.51% decline, pointing to fading momentum as AI related competition...

What Bank of America’s recent share performance might be telling you Bank of America (BAC) shares have slipped about 6% over the past month and past 3 months, and are down roughly 11% year to date, prompting investors to reassess the stock’s current setup. See our latest analysis for Bank of America. With the share price at US$49.81 after a 6.4% decline over the past month, recent weakness contrasts with a 1 year total shareholder return of 11.9% and a 3 year total shareholder return of...